ALPHA TEKNOVA, INC. Debt Securities, Available-for-sale, Unrealized Gain (Loss)
ALPHA TEKNOVA, INC. (TKNO) reported Debt Securities, Available-for-sale, Unrealized Gain (Loss) of -$7.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-30.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss · last filed 2023-03-30
- ALPHA TEKNOVA, INC. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2021-12-31 was $0.00.
- ALPHA TEKNOVA, INC. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2021-09-30 was $0.00.
- ALPHA TEKNOVA, INC. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- ALPHA TEKNOVA, INC. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2021-03-31 was -$7.00K.
- ALPHA TEKNOVA, INC. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2021 was -$7.00K.
- ALPHA TEKNOVA, INC. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2020 was -$13.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | -$7.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | -$7.00K 10-Q · filed 2022-11-14 | -$19.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$7.00K 10-Q · filed 2022-08-11 | -$19.00K derived: sum of 3 quarters · filed 2022-08-11 | -$29.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$7.00K 10-Q · filed 2022-05-12 | -$19.00K derived: sum of 2 quarters · filed 2022-05-12 | -$29.00K derived: sum of 3 quarters · filed 2022-05-12 | $14.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | -$22.00K derived: sum of 2 quarters · filed 2022-03-18 | $21.00K derived: sum of 3 quarters · filed 2022-03-18 | -$13.00K 10-K · filed 2022-03-18 |
| 2020-09-30 | -$10.00K 10-Q · filed 2021-11-12 | $33.00K derived: sum of 2 quarters · filed 2021-11-12 | -$1.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $43.00K 10-Q · filed 2021-08-13 | $9.00K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |